Lazar David E. Insider Trades

Insider Trading History

Track insider trading activity for Lazar David E.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aterian
Aterian ATER
Director
Holding Value $1.87M 1,750,000 shares
Last Trade
Apr 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.15M 1,750,000 shares
$0.66
$1.07
Mainz Biomed N.V.
Mainz Biomed N.V. MYNZ
10% owner, Chief Executive Officer
Holding Value $3.59M 1,000,000 shares
Last Trade
Apr 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.4M 2,000,000 shares
$0.70
$3.59
Sow Good
Sow Good SOWG
Director
Holding Value $8.95M 5,740,000 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.3M 5,740,000 shares
$0.40
$1.56
Indaptus Therapeutics
Indaptus Therapeutics INDP
Director
Holding Value $228k 103,200 shares
Last Trade
Mar 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.55M 896,800 shares
$1.73
$2.21
Mainz Biomed N.V.
Mainz Biomed N.V. MYNZ
Director
Holding Value $3.59M 1,000,000 shares
Last Trade
Feb 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.4M 3,000,000 shares
$0.80
$3.59
Sow Good
Sow Good SOWG
Chief Executive Officer
Holding Value $2.34M 1,500,000 shares
Last Trade
Dec 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$764k 1,500,000 shares
$0.51
$1.56
Sow Good
Sow Good SOWG
Director
Holding Value $1.7M 1,090,000 shares
Last Trade
Dec 31, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$141k 410,000 shares
$0.34
$1.56
Indaptus Therapeutics
Indaptus Therapeutics INDP
Co-chief Executive Officer
Holding Value $0 0 shares
Last Trade
Dec 22, 2025 Sale
$225M 111,000,000 shares
$2.03
$2.21
Kala Bio
Kala Bio KALA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Dec 18, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$213k 368,614 shares
$0.58
$2.24
Kala Bio
Kala Bio KALA
Chief Executive Officer
Holding Value $2.02M 900,000 shares
Last Trade
Nov 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$555k 900,000 shares
$0.62
$2.24
Kala Bio
Kala Bio KALA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Nov 09, 2025 Sale
$263k 368,614 shares
$0.71
$2.24
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
10% owner
Holding Value $9.39M 6,388,000 shares
Last Trade
Oct 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.1M 6,388,000 shares
$5.80
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
10% owner
Holding Value $0 0 shares
Last Trade
Oct 21, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$232k 39,925 shares
$5.80
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
10% owner
Holding Value $58.7k 39,925 shares
Last Trade
Oct 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$503k 441,325 shares
$1.14
$1.47
Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10
Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 CYCCP
10% owner
Holding Value $787k 155,838 shares
Last Trade
Jul 30, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$30.4k 6,750 shares
$4.50
$5.05
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals CYCC
10% owner
Holding Value $992k 155,838 shares
Last Trade
Jul 30, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$83.4k 6,750 shares
$12.36
$6.36
LQR House
LQR House LQR
President
Holding Value $115k 100,000 shares
Last Trade
Apr 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$115k 100,000 shares
$1.15
$1.15
Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10
Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 CYCCP
10% owner, Interim CEO
Holding Value $0 0 shares
Last Trade
Feb 26, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.73B 194,628,820 shares
$8.89
$5.05
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals CYCC
10% owner, Interim CEO
Holding Value $0 0 shares
Last Trade
Feb 26, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$15B 194,628,820 shares
$77.04
$6.36
Minim
Minim MINM
10% owner
Holding Value $9.68M 2,681,980 shares
Last Trade
Feb 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$660k 1,200,000 shares
$0.55
$3.61

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up